Another company involved in using AI to repurpose failed drugs – as well as drugs that have already been approved – is ...

Scientists have developed a coffee machine-sized 3D bioprinter that produces human-like tissue in a move they hope could ...

While PD-1/PD-L1 blockade has demonstrated remarkable clinical successes, recent studies suggest that its novel target has a ...

Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune ...

Pheiron and Ribo are excited to announce that the first two strategic collaboration milestones have been successfully ...

Variations in regulatory requirements across regions often create inefficiencies in drug development—for example, differences in manufacturing standards and stability testing protocols can lead ...

Ionis and Ultragenyx are competing to develop oligonucleotide treatments for Angelman syndrome, but will Neuren’s peptide ...

Orphan Drug Designation follows positive Phase 1 data presented at the 12th International Workshop on Waldenström ...

DevOps and CSV form a powerful duo that, with strategic implementation, promises to propel the pharmaceutical industry.

Taiho Pharmaceutical Co., Ltd.Araris Biotech AGTaiho Pharmaceutical to Acquire Next-Generation ADC Drug Discovery Company Araris ...

The coffee-machine-sized printer produces 3D humanlike tissue that should allow for better testing and development of ...

Preclinical drug evaluation, especially for cardiotoxicity, is a critical stage in the drug development process.